GAMMA Investing’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.9K | Buy |
7,978
+1,485
| +23% | +$16.7K | 0.01% | 1535 |
|
|
2025
Q1 | $65.5K | Buy |
6,493
+2,945
| +83% | +$29.7K | ﹤0.01% | 1594 |
|
|
2024
Q4 | $42K | Buy |
3,548
+1,288
| +57% | +$15.2K | ﹤0.01% | 1793 |
|
|
2024
Q3 | $26.1K | Buy |
2,260
+167
| +8% | +$1.93K | ﹤0.01% | 1946 |
|
|
2024
Q2 | $22.1K | Buy |
2,093
+836
| +67% | +$8.84K | ﹤0.01% | 1789 |
|
|
2024
Q1 | $13.2K | Buy |
1,257
+116
| +10% | +$1.22K | ﹤0.01% | 1895 |
|
|
2023
Q4 | $11.4K | Buy |
+1,141
| New | +$11.4K | ﹤0.01% | 1836 |
|